Related Experiment Videos
Cancer survival in Kampala, Uganda
A Gondos1, H Brenner, H Wabinga
1Department of Epidemiology, German Centre for Research on Ageing, Berghiemer Str. 20, 69115 Heidelberg, Germany. gondos@dzfa.uni-heidelberg.de
British Journal of Cancer
|April 14, 2005
Summary
Cancer survival in Uganda is very poor, especially for colorectal and cervical cancers, compared to Black Americans. Lack of early diagnosis and treatment access significantly impacts patient prognosis in sub-Saharan Africa.
Area of Science:
- Oncology
- Epidemiology
- Public Health
Background:
- Cancer survival data in sub-Saharan Africa are scarce due to logistical challenges.
- Population-based cancer registries are crucial for understanding cancer burden and outcomes.
- Limited access to early diagnosis and treatment contributes to poor cancer prognosis.
Purpose of the Study:
- To estimate 5-year cancer survival rates in Kampala, Uganda.
- To compare cancer survival between Ugandan patients and Black American patients (SEER Program).
- To identify factors influencing cancer prognosis in sub-Saharan Africa.
Main Methods:
- Utilized data from the population-based Cancer Registry of Kampala, Uganda.
- Followed up vital status of cancer patients diagnosed between 1993-1997.
- Compared survival estimates with Black American patients from the US SEER Program.
Main Results:
- Overall 5-year cancer survival in Uganda was very poor.
- Dramatic survival differences observed for colorectal (8.3% Uganda vs. 54.2% US) and cervical cancers (17.7% Uganda vs. 63.9% US).
- High-quality follow-up data collection was feasible in the African setting.
Conclusions:
- Poor cancer prognosis in Uganda is linked to limited access to early diagnosis and treatment.
- Consistent implementation of national cancer control programs is vital.
- Urgent need for improved cancer care infrastructure and accessibility in sub-Saharan Africa.